Drug Type Mesenchymal stem cell therapy |
Synonyms UC-MSCs(Zhongyuan Union Stem Cell Bioengineering Co., Ltd.) |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
cirrhosis due to hepatitis B | Phase 1 | CN | 20 Jul 2021 |